Table 3.

Total and potentially treatment-related numbers of adverse events over the 3-month controlled period.

	Treatment groups		p
	W-TENS	WO
ITT Population (N)	55	55
Total number of AE	24	55
Number of potentially treatment-related AEs: n (%)	7 (29.2)	36 (65.5)	<0.0001
95% CI	[11.0, 47.4]	[52.9, 78.0]

AEs, adverse events; CI, confidence interval; n, number; %, percentage; WO, weak opioid; W-TENS, wearable transcutaneous electrical nerve stimulation.

Percentages and corresponding 95% CI.